Showing results (251-260 of 271) with videos related to
Sort By:
Pageof 28
Circulation|April 20, 2021
Genetic and Phenotypic Landscape of Peripartum CardiomyopathyRahul Goli, Jian Li, Jeff Brandimarto, et al.ESC Heart Failure|May 15, 2021
Multimodality assessment of heart failure with preserved ejection fraction skeletal muscle reveals differences in the machinery of energy fuel metabolismPayman Zamani, Elizabeth A Proto, Neil Wilson, et al.JACC. Basic to Translational Science|April 10, 2023
Apolipoprotein M Attenuates Anthracycline Cardiotoxicity and Lysosomal InjuryZhen Guo, Carla Valenzuela Ripoll, Antonino Picataggi, et al.Circulation. Genomic and Precision Medicine|March 16, 2018
Genetic Reduction in Left Ventricular Protein Kinase C-α and Adverse Ventricular Remodeling in Human SubjectsRay Hu, Michael P Morley, Jeffrey Brandimarto, et al.Circulation. Heart Failure|April 5, 2021
Characteristics and Outcomes of COVID-19 in Patients on Left Ventricular Assist Device SupportEdo Y Birati, Samer S Najjar, Ryan J Tedford, et al.Proceedings of the National Academy of Sciences of the United States of America|July 16, 2025
Systemic delivery of biotherapeutic RNA to the myocardium transiently modulates cardiac contractility in vivoVladimir V Shuvaev, Ying K Tam, Benjamin W Lee, et al.Circulation|August 14, 2025
Human Single-Nucleus RNA Sequencing Identifies CD47 as a Therapeutic Target for Doxorubicin-Induced CardiomyopathyZhen Guo, Anahita Ataran, Pan Ma, et al.Nature Communications|June 26, 2019
Pathologic gene network rewiring implicates PPP1R3A as a central regulator in pressure overload heart failurePablo Cordero, Victoria N Parikh, Elizabeth T Chin, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 18, 2021
Coronavirus disease 2019 in heart transplant recipients: Risk factors, immunosuppression, and outcomesMichael V Genuardi, Noah Moss, Samer S Najjar, et al.JAMA|November 20, 2013
Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trialHorng H Chen, Kevin J Anstrom, Michael M Givertz, et al.Pageof 28